TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 20.17%91.12M | 7.60%162.28M | 9.21%120.28M | 11.41%75.83M | 16.27%33.48M | 4.45%150.82M | -0.26%110.14M | -2.09%68.07M | 7.45%28.79M | 28.11%144.4M |
Operating income | 20.17%91.12M | 7.60%162.28M | 9.21%120.28M | 11.41%75.83M | 16.27%33.48M | 4.45%150.82M | -0.26%110.14M | -2.09%68.07M | 7.45%28.79M | 28.11%144.4M |
Cost of sales | -18.15%-53.94M | -1.45%-96.91M | 0.37%-71.81M | -5.14%-45.65M | -5.26%-20.15M | -13.24%-95.53M | -14.74%-72.08M | -4.91%-43.42M | -22.97%-19.14M | -28.06%-84.36M |
Operating expenses | -18.15%-53.94M | -1.45%-96.91M | 0.37%-71.81M | -5.14%-45.65M | -5.26%-20.15M | -13.24%-95.53M | -14.74%-72.08M | -4.91%-43.42M | -22.97%-19.14M | -28.06%-84.36M |
Gross profit | 23.22%37.18M | 18.22%65.36M | 27.33%48.46M | 22.45%30.18M | 38.09%13.33M | -7.91%55.29M | -20.06%38.06M | -12.39%24.65M | -14.06%9.65M | 28.17%60.04M |
Selling expenses | -25.26%-12.94M | -19.42%-24.25M | -16.91%-16.6M | -8.39%-10.33M | -21.28%-4.64M | -21.43%-20.31M | -16.84%-14.2M | -18.52%-9.53M | -5.81%-3.83M | -4.82%-16.72M |
Administrative expenses | -25.86%-11.05M | -24.63%-20.95M | -5.81%-13.65M | 2.42%-8.78M | 6.44%-4.57M | 20.99%-16.81M | 10.03%-12.9M | 6.67%-9M | -2.33%-4.88M | -33.89%-21.28M |
Research and development expenses | -50.99%-8.07M | -9.16%-11.59M | -8.42%-8.28M | -8.98%-5.34M | -31.24%-2.59M | 0.80%-10.61M | -11.71%-7.64M | -26.25%-4.9M | -59.47%-1.98M | -45.20%-10.7M |
Impairment and provision | ---- | -244.07%-1.98M | ---- | ---- | ---- | -69.63%-576.09K | ---- | ---- | ---- | -10.82%-339.61K |
-Other impairment is provision | ---- | -244.07%-1.98M | ---- | ---- | ---- | -69.63%-576.09K | ---- | ---- | ---- | -10.82%-339.61K |
Special items of operating profit | -46.36%1.05M | 139.81%2.58M | 27.21%1.66M | 207.07%1.95M | 191.30%200.11K | -67.89%1.08M | -36.03%1.31M | -48.07%636.58K | -90.83%68.69K | 1,985.58%3.35M |
Operating profit | -19.57%6.18M | 13.83%9.17M | 150.41%11.59M | 314.46%7.68M | 279.01%1.73M | -43.85%8.06M | -71.64%4.63M | -76.22%1.85M | -140.98%-964.4K | 91.74%14.35M |
Financing income | 117.02%49.63K | 514.72%230.56K | 1,517.57%341.31K | 73.26%22.87K | -29.04%3.56K | 34.58%37.51K | -10.27%21.1K | -44.30%13.2K | -60.42%5.02K | 22.00%27.87K |
Financing cost | 8.87%-3.19M | -4.31%-6.77M | 0.52%-5.17M | -7.96%-3.5M | -66.49%-2.32M | -7.93%-6.49M | -22.05%-5.2M | -22.23%-3.24M | -12.27%-1.4M | 2.57%-6.01M |
Earning before tax | -27.74%3.04M | 63.81%2.64M | 1,329.17%6.76M | 405.50%4.2M | 74.83%-592.63K | -80.76%1.61M | -104.55%-550.07K | -126.65%-1.38M | -309.54%-2.35M | 524.65%8.37M |
Tax | -33.03%-232.79K | -76.31%-334.85K | -375.87%-517.03K | -147.16%-175K | -50.37%309.88K | 79.70%-189.92K | 111.16%187.42K | 135.42%371.04K | 1,288.15%624.37K | -474.37%-935.44K |
After-tax profit from continuing operations | -30.38%2.8M | 62.14%2.3M | 1,821.82%6.24M | 500.88%4.03M | 83.66%-282.75K | -80.90%1.42M | -103.48%-362.66K | -124.42%-1M | -261.53%-1.73M | 531.61%7.43M |
Earning after tax | -30.38%2.8M | 62.14%2.3M | 1,821.82%6.24M | 500.88%4.03M | 83.66%-282.75K | -80.90%1.42M | -103.48%-362.66K | -124.42%-1M | -261.53%-1.73M | 531.61%7.43M |
Profit attributable to shareholders | -30.38%2.8M | 62.14%2.3M | 1,821.82%6.24M | 500.88%4.03M | 83.66%-282.75K | -80.90%1.42M | -103.48%-362.66K | -124.42%-1M | -261.53%-1.73M | 531.61%7.43M |
Basic earnings per share | -30.48%0.073 | 50.00%0.06 | 1,700.00%0.16 | 503.85%0.105 | 80.00%-0.01 | -78.95%0.04 | -103.70%-0.01 | -124.30%-0.026 | -266.67%-0.05 | 533.33%0.19 |
Diluted earnings per share | -30.48%0.073 | 50.00%0.06 | 1,700.00%0.16 | 503.85%0.105 | 80.00%-0.01 | -78.95%0.04 | -103.70%-0.01 | -124.30%-0.026 | -266.67%-0.05 | 533.33%0.19 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | -- | -- | PricewaterhouseCoopers | -- | -- | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.